Trial Profile
A phase I clinical trial of Herceptin biosimilar
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 28 Apr 2017 New trial record